Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?
Rosenberg
R D
RD
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA. rdrrosen@mit.edu
Shworak
N W
NW
Liu
J
J
Schwartz
J J
JJ
Zhang
L
L
D001777:Blood Coagulation; D002319:Cardiovascular System / Q000201:enzymology / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism; D006493:Heparin / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D015394:Molecular Structure; D011509:Proteoglycans / Q000096:biosynthesis / Q000737:chemistry* / Q000378:metabolism*; D019998:Racemases and Epimerases / Q000378:metabolism; D013379:Substrate Specificity
D006133:Growth Substances; D008074:Lipoproteins; D011509:Proteoglycans; C036090:heparin proteoglycan; D006493:Heparin; D019998:Racemases and Epimerases